Latest Breaking News On - Biologics licensing application - Page 3 : comparemela.com

United States Food & Drug Administration (FDA) Grants Mesoblast Rare Pediatric Disease Designation for Revascor (Rexlemestrocel-L) in Children With Congenital Heart Disease

19.01.2024 - REVASCOR Increases Size of Left Heart Chamber and Improves Surgical Outcomes in Children with Hypoplastic Left Heart Syndrome: Results Published in Journal of Thoracic and Cardiovascular Surgery Open NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) - . Seite 1

United statesBiologics licensing applicationPriority review voucherCardiovascular surgery openMesoblast aktieEsoblast ltd shs old aktie

Why are Mesoblast shares rocketing 28% today?

Why are Mesoblast shares rocketing 28% today?
fool.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com.au Daily Mail and Mail on Sunday newspapers.

United statesSilviu itescuDrug administrationMesoblast ltdUnited states foodRare pediatric diseaseBiologics licensing applicationPriority review voucherChief executive

Mesoblast (MESO) Granted FDA Rare Pediatric Disease Designation for Revascor

Mesoblast (MESO) Granted FDA Rare Pediatric Disease Designation for Revascor
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSilviu itescuMesoblast limited nasdaqDrug administrationMesoblast limitedUnited states foodRare pediatric diseaseBiologics licensing applicationPriority review voucherCardiovascular surgery openChief executive silviu itescu

Microbix Biosystems : Earnings Document -December 20, 2023 at 11:06 pm EST

MICROBIX BIOSYSTEMS INC. ANNUAL REPORT 2023 Message to.

Province of ontarioUnited statesCopan italiaMicrobix qapsCameronl groomeBiogx decStates decUlisse biomedMicrobix dxHealth canada medical devices establishmentEconomic development agency for southern ontarioPublic health agency of canadaInternational accounting standards boardCompany management discussionMicrobix biosystems incQuidelortho corporation

ImmunoGen: Elahere Data Mid-2024 To Expand Targeted Population (NASDAQ:IMGN)

ImmunoGen: Elahere Data Mid-2024 To Expand Targeted Population (NASDAQ:IMGN)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Immunogen incEuropean medicines agencyNational medical products administration of elahereEuropean unionAccelerated approvalFolate receptorBiologics licensing applicationHuadong medicineNew drug applicationNational medical products administrationTakeda pharmaceutical